iRhythm Holdings (IRTC) EBT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 2,828.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,828.00 |
| Dec 31, 2025 | 2,076.00 |
| Sep 30, 2025 | 1,785.00 |
| Jun 30, 2025 | 1,567.00 |
| Mar 31, 2025 | 3,581.00 |
| Dec 31, 2024 | 3,893.00 |
| Sep 30, 2024 | -351.00 |
| Jun 30, 2024 | 777.00 |
| Mar 31, 2024 | 266.00 |
| Dec 31, 2023 | -1,674.00 |
| Sep 30, 2023 | -1,525.00 |
| Jun 30, 2023 | 2,519.00 |
| Mar 31, 2023 | -2,078.00 |
| Dec 31, 2022 | 1,137.00 |
| Sep 30, 2022 | 1,288.00 |
| Jun 30, 2022 | -296.00 |
| Mar 31, 2022 | -3,769.00 |
| Dec 31, 2021 | -81.00 |
| Sep 30, 2021 | -236.00 |
| Jun 30, 2021 | 1,337.00 |
| Mar 31, 2021 | -225.00 |
| Dec 31, 2020 | 2,961.00 |
| Sep 30, 2020 | 2,099.00 |
| Jun 30, 2020 | -1,157.00 |
| Mar 31, 2020 | 1,173.00 |
| Dec 31, 2019 | -140.00 |
| Sep 30, 2019 | -1,273.00 |
| Jun 30, 2019 | 818.00 |
| Mar 31, 2019 | 2,704.00 |
| Dec 31, 2018 | 3,004.00 |
| Sep 30, 2018 | 3,593.00 |